Literature DB >> 170344

The ontogeny of murine B lymphocytes. I. Induction of phenotypic conversion of Ia-to Ia+ lymphocytes.

U Hammerling, A F Chin, J Abbott, M P Scheid.   

Abstract

When bone marrow and spleen cells of 4 week-old mice are fractionated on a discontinuous BSA gradient, a small fraction of Ia- cells is obtained which can be induced in vitro to express the Ia alloantigen within 2 hr. This is in precise parallel to the prothymocyte induction system of Komuro and Boyse. Ia specificity is ascertained by the use of two reciprocal antisera, A.TH anti-A.TL (anti-Iak) and A.TL anti-A.TH (anti-Ias), which yield the expected reaction pattern on induced bone marrow cells of (B6 X A)F1 (Iak) and SJL/J (Ias) mice. Induction can be effected by a number of agents, such as catecholamines, prostaglandin PGE1, cAMP, bacterial endotoxin, lipid A, ubiquitin, and thymopoietin. The last requires a 100-fold higher concentration for Ia+ induction as compared to prothymocyte induction, thus implying a lower affinity for the B cell receptor than for the thymocyte receptor. Ia- to Ia+ conversion involves cells different from prothymocytes, as indicated by: 1) the specific cytolytic effect of our anti-Ia sera which were shown to be free of activity against thymocytes; 2) an additive cytolytic effect of anti-Ia and anti-Thy-1 sera; and 3) the fact that the Ia inducible cells are sensitive to pretreatment with anti-immunoglobulin and C. This finding that Ia- precursor cells are already Ig+ is of interest for the B cell ontogeny, as it implies that Ig expression precedes Ia expression.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 170344

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Ontogeny of murine B lymphocytes: sequence of B-cell differentiation from surface-immunoglobulin-negative precursors to plasma cells.

Authors:  U Hämmerling; A F Chin; J Abbott
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

2.  The generation and regulation of lymphocyte populations: evidence from differentiative induction systems in vitro.

Authors:  M P Scheid; G Goldstein; E A Boyse
Journal:  J Exp Med       Date:  1978-06-01       Impact factor: 14.307

3.  Endotoxin-induced serum factor controlling differentiation of bone-marrow-derived lymphocytes.

Authors:  M K Hoffmann; H F Oettgen; L J Old; A F Chin; U Hammerling
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

4.  Primary in vitro plaque-forming cell response to DAGG-Ficoll: LPS-induced enhancement mediated by interleukin-1.

Authors:  J L Curtis; A A Nordin
Journal:  Immunology       Date:  1984-08       Impact factor: 7.397

5.  Induction of immune and adjuvant immunoglobulin G responses in mice by Brucella lipopolysaccharide.

Authors:  E Moreno; R S Kurtz; D T Berman
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

6.  Severe combined immunodeficiency disease: a model of T-cell dysfunction.

Authors:  H M Dosch; J W Lee; E W Gelfand; J A Falk
Journal:  Clin Exp Immunol       Date:  1978-11       Impact factor: 4.330

7.  Bacterial lipopolysaccharide activates suppressor B lymphocytes.

Authors:  S Koenig; M K Hoffmann
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

8.  Ontogeny of antigen-presenting activity of haptenized cells in mice: early development of syngeneic T cell-stimulatory cells in thymus.

Authors:  M Hosono; Y Katsura; S Muramatsu
Journal:  Immunology       Date:  1984-01       Impact factor: 7.397

9.  Maturation of bone marrow lymphocytes. IV. Kinetics of maturation and renewal of lymphocytes expressing Ia and H-2K antigens.

Authors:  M D Rahal; D G Osmond
Journal:  Immunology       Date:  1981-11       Impact factor: 7.397

10.  Ontogeny of B-lymphocyte function. V. Thymus cell involvement in the functional maturation of B-lymphocytes from fetal mice transferred into adult irradiated hosts.

Authors:  D H Sherr; M R Szewczuk; G W Siskind
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.